If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrism Thera Share News (CRTX)

Share Price Information for Crism Thera (CRTX)

Share Price is delayed by 15 minutes
Get Live Data
10.25    -0.50 (-4.65%)
Bid:
10.00
Ask:
10.50
Spread: 0.50 (5.00%)
Market Cap: £8.12m
CRTX Live PriceLast checked at - London Stock Exchange

Intraday Crism Thera Share Chart

Crism Thera News

Crism Therapeutics gets clearance for UK phase 2 trial
1 Sep 2025

Crism Therapeutics gets clearance for UK phase 2 trial

(Sharecast News) - Crism Therapeutics said on Monday that it has received both regulatory clearance from the UK Medicines and Healthcare products Regu...

IN BRIEF: CRISM confident in ChemoSeed as targets trial approval
26 Aug 2025

IN BRIEF: CRISM confident in ChemoSeed as targets trial approval

CRISM Therapeutics Corp - British Virgin Islands-based pharmaceutical firm - As the firm held its annual general meeting, Chair Nermeen Varawalla says...

Crism reports progress with ChemoSeed drug delivery platform
26 Aug 2025

Crism reports progress with ChemoSeed drug delivery platform

(Sharecast News) - Crism Therapeutics used its annual general meeting on Tuesday to highlight progress on its ChemoSeed drug delivery platform as it a...

LONDON MARKET MIDDAY: London mixed as mortgage data beats expectations
30 Jun 2025

LONDON MARKET MIDDAY: London mixed as mortgage data beats expectations

(Alliance News) - London stocks were mixed at midday on Monday, as US tariff uncertainty continues to weigh on investor sentiment despite a data readi...

AIM WINNERS & LOSERS: MediaZest swings to profit, remains optimistic
30 Jun 2025

AIM WINNERS & LOSERS: MediaZest swings to profit, remains optimistic

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Monday.

CRISM Therapeutics hails progress in glioblastoma as loss widens
13 Jun 2025

CRISM Therapeutics hails progress in glioblastoma as loss widens

(Alliance News) - CRISM Therapeutics Corp on Friday said it is confident in its prospects, citing progress in glioblastoma, as it reported an increase...

CRISM Therapeutics sets up advisory board ahead of ChemoSeed trial
3 Jun 2025

CRISM Therapeutics sets up advisory board ahead of ChemoSeed trial

(Alliance News) - CRISM Therapeutics Corp on Tuesday said it has established a scientific advisory board as it prepares to submit a clinical trial app...